HALO logo
halo search icon
Recursion Pharmaceuticals, Inc. Class A

US$2.96

Price Change Indicator
0.11 (3.86%)
Recursion Pharmaceuticals, Inc. Class A
RXRX · NAS

Recursion Pharmaceuticals, Inc. Class A

Start Trading RXRX for Free

US$2.96

Price Arrow0.11 (3.86%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueHALO Earnings MomentumHammer Bullish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Recursion Pharmaceuticals, Inc. Class A Overview

RXRX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

About RXRX

icon

Website

Recursion Pharmaceuticals, Inc. Class A

icon

Telephone

1.385.269.0203

icon

Address

41 South Rio Grande Street, Salt Lake City, UT 84101

Description

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.

RXRX Price Chart

Key Stats

Market Cap

US$1.50B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 2.77 - 7.18

Trade Value (12mth)

US$32,836,512.00

1 week

-2.73%

1 month

-19.94%

YTD

-32.14%

1 year

-30.4%

All time high

42.81

Key Fundamentals

EPS 3 yr Growth

5.60%

EBITDA Margin

-755.80%

Operating Cashflow

-$372m

Free Cash Flow Return

-32.20%

ROIC

-55.90%

Interest Coverage

-311.80

Quick Ratio

5.50

Other Data

Shares Outstanding (Fully Diluted)

529m

HALO Sector

Healthcare

Next Company Report Date

03-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

RXRX Announcements

Latest Announcements

DateAnnouncements
06 May 26
06 May 26
06 May 26
06 May 26
01 May 26

RXRX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.58-1.69-1.44locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.58-1.69-1.44locklocklock
Growth
 %locklocklocklock-15.7-7.114.8locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Recursion Pharmaceuticals, Inc. Class A (RXRX:NAS)?
Halo FAQ
The current share price of Recursion Pharmaceuticals, Inc. Class A (RXRX:NAS) is USD$2.96.
What is the 52-week high share price for Recursion Pharmaceuticals, Inc. Class A (RXRX:NAS)?
Halo FAQ
The 52-week high share price for Recursion Pharmaceuticals, Inc. Class A (RXRX:NAS) is USD$7.18.
What is the 52-week low share price for Recursion Pharmaceuticals, Inc. Class A (RXRX:NAS)?
Halo FAQ
The 52-week low share price for Recursion Pharmaceuticals, Inc. Class A (RXRX:NAS) is USD$2.77.
What is the dividend yield for Recursion Pharmaceuticals, Inc. Class A (RXRX:NAS)?
Halo FAQ
Recursion Pharmaceuticals, Inc. Class A (RXRX:NAS) does not pay a dividend.
What was Recursion Pharmaceuticals, Inc. Class A (RXRX:NAS) last dividend payment?
Halo FAQ
Recursion Pharmaceuticals, Inc. Class A (RXRX:NAS) does not pay a dividend.
What is the franking level for Recursion Pharmaceuticals, Inc. Class A (RXRX:NAS)?
Halo FAQ
Recursion Pharmaceuticals, Inc. Class A (RXRX:NAS) has a franking level of 0.00%.
In which sector is Recursion Pharmaceuticals, Inc. Class A (RXRX:NAS) classified?
Halo FAQ
Recursion Pharmaceuticals, Inc. Class A (RXRX:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial